Plasma ceramides are altered in mild cognitive impairment and predict cognitive decline and hippocampal volume loss

A blood-based biomarker of Alzheimer's disease (AD) would be superior to cerebrospinal fluid (CSF) and neuroimaging measures in terms of cost, invasiveness, and feasibility for repeated measures. We previously reported that blood ceramides varied in relation to timing of memory impairment in a...

Celý popis

Uloženo v:

Podrobná bibliografie
Vydáno v:	Alzheimer's & dementia Ročník 6; číslo 5; s. 378
Hlavní autoři:	Mielke, Michelle M, Haughey, Norman J, Bandaru, Veera Venkata Ratnam, Schech, Steven, Carrick, Richard, Carlson, Michelle C, Mori, Susumu, Miller, Michael I, Ceritoglu, Can, Brown, Timothy, Albert, Marilyn, Lyketsos, Constantine G
Médium:	Journal Article
Jazyk:	angličtina
Vydáno:	United States 01.09.2010
Témata:	Aged Aged, 80 and over Alzheimer Disease - blood Analysis of Variance Ceramides - blood Ceramides - classification Cognition Disorders - blood Cognition Disorders - pathology Female Functional Laterality Hippocampus - pathology Humans Linear Models Magnetic Resonance Imaging - methods Male Neuropsychological Tests Predictive Value of Tests Psychiatric Status Rating Scales
ISSN:	1552-5279, 1552-5279
On-line přístup:	Zjistit podrobnosti o přístupu
Tagy:	Přidat tag Žádné tagy, Buďte první, kdo vytvoří štítek k tomuto záznamu!

Buďte první, kdo okomentuje tento záznam!